We are live on ! Find out more
BNR

Burning Rock Biotech
BNR

58 hedge funds and large institutions have $474M invested in Burning Rock Biotech in 2020 Q4 according to their latest regulatory filings, with 25 funds opening new positions, 18 increasing their positions, 7 reducing their positions, and 5 closing their positions.

New
Increased
Maintained
Reduced
Closed

400% more funds holding in top 10

Funds holding in top 10: 1 → 5 (+4)

400% more first-time investments, than exits

New positions opened: 25 | Existing positions closed: 5

157% more repeat investments, than reductions

Existing positions increased: 18 | Existing positions reduced: 7

53% more funds holding

Funds holding: 38 → 58 (+20)

20% more capital invested

Capital invested by funds: $396M → $474M (+$77.9M)

0.48% more ownership

Funds ownership: 1.89% → 2.37% (+0.48%)

Holders
58
Holders Change
+20
Holders Change %
+52.63%
% of All Funds
1.03%
Holding in Top 10
5
Holding in Top 10 Change
+4
Holding in Top 10 Change %
+400%
% of All Funds
0.09%
New
25
Increased
18
Reduced
7
Closed
5
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Jennison Associates
Jennison Associates
New York
+$32.7M
2
Fidelity Investments
Fidelity Investments
Massachusetts
+$24.2M
3
Baillie Gifford & Co
Baillie Gifford & Co
United Kingdom
+$15.2M
4
NAMA
Nikko Asset Management Americas
New York
+$10.8M
5
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group
Japan
+$10.8M

Top Sellers

Rank Fund Capital Flow
1
O
OrbiMed
New York
-$15.7M
2
HA
HHLR Advisors
Cayman Islands
-$10M
3
PVI
Pura Vida Investments
New York
-$4.43M
4
HSBC Holdings
HSBC Holdings
United Kingdom
-$3.11M
5
GAM
Greenwoods Asset Management
Cayman Islands
-$2.51M
Name Holding Trade Value Shares
Change 		Change in
Stake
Millennium Management
26
Millennium Management
New York
$3.18M -$822K -3,061 -18%
MIM
27
Monashee Investment Management
Massachusetts
$1.85M +$2.15M +8,000 New
HLA
28
Hamilton Lane Advisors
Pennsylvania
$1.03M +$1.19M +4,442 New
TD Asset Management
29
TD Asset Management
Ontario, Canada
$972K – – –
Prudential Financial
30
Prudential Financial
New Jersey
$949K +$1.1M +4,106 New
NEI
31
Northwest & Ethical Investments
Ontario, Canada
$920K – – –
MWA
32
Marshall Wace Asia
Hong Kong
$913K -$662K -2,465 -38%
RI
33
RTW Investments
New York
$693K – – –
Axa
34
Axa
France
$647K +$215K +800 +40%
Tudor Investment Corp
35
Tudor Investment Corp
Connecticut
$597K +$694K +2,585 New
SSA
36
Schonfeld Strategic Advisors
New York
$578K +$671K +2,500 New
Norges Bank
37
Norges Bank
Norway
$462K – – –
Alyeska Investment Group
38
Alyeska Investment Group
Illinois
$458K +$533K +1,984 New
Qube Research & Technologies (QRT)
39
Qube Research & Technologies (QRT)
United Kingdom
$402K +$468K +1,742 New
MIOT
40
Massachusetts Institute of Technology
Massachusetts
$349K +$405K +1,510 New
Invesco
41
Invesco
Georgia
$310K +$360K +1,342 New
DI
42
DUMAC Inc
North Carolina
$248K +$288K +1,072 New
PCM
43
Prelude Capital Management
New York
$245K -$47.3K -176 -14%
PPA
44
Parametric Portfolio Associates
Washington
$243K – – –
VIA
45
Vident Investment Advisory
Georgia
$240K -$1.34K -5 -0.5%
LMGAM
46
Liberty Mutual Group Asset Management
Massachusetts
$231K +$268K +998 New
JG
47
Jefferies Group
New York
$231K +$268K +1,000 New
MCCP
48
Mission Creek Capital Partners
California
$225K +$261K +972 New
VU
49
Vanderbilt University
Tennessee
$218K +$253K +943 New
GGHC
50
Gilder Gagnon Howe & Co
New York
$202K +$199K +743 +572%
1
2
3

BNR Hedge Fund Activity: Q4 2020 in Review

58 of the 5,651 institutional investors tracked by Wall St. Rank reported a position in Burning Rock Biotech (BNR) for Q4 2020, worth a combined $474M — up 20% from $396M a quarter earlier.

Buyers outnumbered sellers: 25 funds opened new BNR positions and 5 closed out — a net gain of 20 holders — while 18 added to existing stakes and 7 trimmed.

The largest buyer was Jennison Associates, adding an estimated $32.7M. The largest seller was OrbiMed, cutting an estimated $15.7M.

  • 58 institutional investors held Burning Rock Biotech (BNR) as of Q4 2020, up from 38 in Q3 2020.
  • Funds reported $474M of Burning Rock Biotech stock for Q4 2020, up 20% quarter-over-quarter.
  • 25 funds opened new Burning Rock Biotech positions in Q4 2020 and 5 closed out, a net change of +20 holders.
  • The largest Burning Rock Biotech buyer in Q4 2020 was Jennison Associates, an estimated $32.7M added.
  • The largest Burning Rock Biotech seller in Q4 2020 was OrbiMed, an estimated $15.7M sold.

Based on aggregated 13F filings for Q4 2020.